C. Bolm et al. / Tetrahedron: Asymmetry 12 (2001) 2441–2446
2445
being stirred for 0.5×1 h at ambient temperature, the
ketone was added to the suspension, which became
more homogeneous after stirring for an additional 15
min. The mixture was cooled to −25°C before addition
of hydroperoxide (1.5 equiv.) and then slowly allowed
to warm to ambient temperature again. After stirring
for 12 h, the mixture was treated with aqueous HCl (0.5
M) and the aqueous layer was extracted with MTBE.
The combined organic layers were washed with a satu-
rated aqueous solution of NaHCO3, dried over anhy-
drous MgSO4, filtered, and directly submitted to GC
analysis.
stirred for 1 h at ambient temperature and then cooled
to −20°C. Subsequently, the allylic alcohol was added
via syringe, followed, after 15 min, by the hydroperox-
ide (1.5 equiv.). After stirring the mixture for 3 days,
the reaction was quenched with aqueous Na2SO3 (1 M),
and the mixture was extracted with MTBE. The com-
bined organic layers were dried over anhydrous
MgSO4, filtered and concentrated under reduced pres-
sure. The epoxide was purified by flash column chro-
matography on silica gel.
When the enantiomeric excess of the remaining (1-
phenyl)ethyl hydroperoxide was to be determined, the
crude reaction mixture was directly submitted to
column chromatography without any work-up.
When yields of isolated products were to be deter-
mined, 1–2 mmol of ketone was employed and the
product was purified by flash column chromatography
(silica, petroleum ether:MTBE, 2:1).
3.4.2. Procedure for the experiments with the shift
reagent Eu(tfc)3. Acetic anhydride (50 mL) was added to
a solution of 2,3-epoxygeraniol 13 (30 mg) in dry
pyridine (0.5 mL). The resulting mixture was stirred at
ambient temperature for 2 h and then diluted with
petroleum ether (0.5 mL). The formed acetate was
purified by flash column chromatography (silica,
petroleum ether:MTBE, 2:1, Rf 0.75). The enantiomeric
3.3.5. ( )-cis-Hexahydro-2(3H)-benzofuranone 4a. 1H
NMR (300 MHz, CDCl3) l 1.20–1.34 (m, 2H), 1.43–
1.54 (m, 2H), 1.58–1.77 (m, 3H), 2.03–2.12 (m, 1H),
2.25 (dd, J=16.4, 2.4 Hz, 1H), 2.35–2.45 (m, 1H), 2.62
(dd, J=16.8, 6.9 Hz, 1H), 4.52 (ddd, J1=J2=J3=4.3
Hz, 1H); 13C NMR (75 MHz, CDCl3) l 19.7, 22.6,
27.0, 27.6, 34.7, 37.3, 79.1, 177.6; GC: Lipodex B (25
m×0.25 mm) with pre-column (3 m×0.25 mm), 60 kPa
N2, either 120°C isotherm with tR=37.7 min [(+)-
(3aR,7aR)] and 41.0 min [(−)-(3aS,7aS)] or 120°C, 2°C/
min, 150°C, 5 min with tR=17.6 min [(+)-(3aR,7aR)]
and 18.2 min [(−)-(3aS,7aS)].15
1
excess was determined by H NMR analysis of a solu-
tion of the acetate and Eu(tfc)3 (8 mg) in C6D6 (1 mL)
by integrating the signal at l 1.04 ppm.
3.4.3. ( )-2,3-Epoxy-2-methyl-3-phenylpropan-1-ol 11. Rf
0.22 (petroleum ether:MTBE, 1:1); 1H NMR (400
MHz, CDCl3) l 1.09 (s, 3H), 2.18 (dd, J=8.5, 4.1 Hz,
1H), 3.76 (dd, J=12.5, 8.7 Hz, 1H), 3.86 (dd, J=12.5,
4.0 Hz, 1H), 4.22 (s, 1H), 7.28–7.39 (m, 5H); 13C NMR
(100 MHz, CDCl3) l 13.7, 60.4, 64.0, 65.2, 126.6, 127.8,
128.3, 135.8; HPLC (Chiralcel OD, hexane:i-PrOH,
97:3, 0.8 mL/min, 25°C): tR=19.0 min (2S,3S) and 26.3
min (2R,3R).
1
3.3.6. ( )-cis-Hexahydro-1(3H)-isobenzofuranone 4b. H
NMR (400 MHz, CDCl3) l 1.19–1.24 (m, 3H), 1.56–
1.67 (m, 3H), 1.77–1.85 (m, 1H), 2.10–2.13 (m, 1H),
2.44–2.51 (m, 1H), 2.63–2.67 (m, 1H), 3.96 (dd, J=9.1,
1.4 Hz, 1H), 4.20 (dd, J=8.8, 5.2 Hz, 1H); 13C NMR
(100 MHz, CDCl3) l 22.5, 22.9, 23.4, 27.2, 35.4, 39.5,
71.7, 178.3; GC: Lipodex B (25 m×0.25 mm) with
pre-column (3 m×0.25 mm), 60 kPa N2, either 120°C
isotherm with tR=24.6 min [(−)-(3aS,7aR)] and 26.1
min [(+)-(3aR,7aS)] or 120°C, 2°C/min, 150°C, 5 min
with tR=14.3 min [(−)-(3aS,7aR)] and 14.7 min [(+)-
(3aR,7aS)].16
3.4.4. ( )-2,3-Epoxygeraniol 13. Rf 0.19 (petroleum
1
ether:MTBE, 1:1); H NMR (400 MHz, CDCl3) l 1.30
(s, 3H), 1.43–1.52 (m, 1H), 1.61 (s, 3H), 1.64–1.72 (m,
1H), 1.69 (d, J=1.1 Hz, 3H), 1.96 (dd, J=7.3, 4.8 Hz,
1H), 2.09 (q, J=8.0 Hz, 2H), 2.98 (dd, J=6.8, 4.3 Hz,
1H), 3.64–3.72 (m, 1H), 3.79–3.87 (m, 1H), 5.06–5.11
(m, 1H); 13C NMR (100 MHz, CDCl3) l 16.7, 17.6,
23.7, 25.7, 38.4, 61.1, 61.4, 62.9, 123.2, 132.0.
3.3.7. ( )-4-Phenyltetrahydro-2-furanone 6. 1H NMR
(400 MHz, CDCl3) l 2.65 (dd, J=17.3, 9.1 Hz, 1H),
2.90 (dd, J=17.3, 8.5 Hz, 1H), 3.78 (quin, J=8.2 Hz,
1H), 4.24 (t, J=8.6 Hz, 1H), 4.64 (t, J=8.5 Hz, 1H),
7.21–7.24 (m, 2H), 7.26–7.31 (m, 1H), 7.34–7.38 (m,
2H); 13C NMR (100 MHz, CDCl3) l 35.5, 40.9, 73.8,
126.5, 127.4, 128.8, 139.2, 176.1; GC: Lipodex B (25
m×0.25 mm) with pre-column (3 m×0.25 mm), 60 kPa
N2 at 140°C, 140°C, 15 min, 2°C/min, 160°C, 50 min
with tR=65.0 min [(+)-(S)] and 66.6 min [(−)-(R)].17
3.4.5. Acetate of ( )-2,3-epoxygeraniol 13. 1H NMR
(400 MHz, C6D6) l 1.04 (s, 3H), 1.31–1.39 (m, 1H),
1.48 (s, 3H), 1.48–1.56 (m, 1H), 1.63 (d, J=1.1 Hz,
3H), 1.66 (s, 3H), 1.96–2.03 (m, 2H), 2.89 (dd, J=6.6,
4.4 Hz, 1H), 3.99 (dd, J=12.1, 6.6 Hz, 1H), 4.19 (dd,
J=12.1, 4.4 Hz, 1H), 5.03–5.09 (m, 1H); 13C NMR
(100 MHz, C6D6) l 16.8, 17.6, 20.2, 23.9, 25.7, 38.5,
1
59.5, 59.8, 63.5, 123.9, 131.6, 169.7; H NMR experi-
ment with the shift reagent Eu(tfc)3: l 1.16 (2S,3S) and
1.19 (2R,3R).
3.4. Asymmetric epoxidation
3.4.1. General procedure for the epoxidation of allylic
alcohols. VO(Oi-Pr)3 (5 mol%) and ligand 14 (7.5
mol%) were dissolved in dry toluene under an argon
atmosphere. The resulting deep red solution was first
3.4.6. ( )-(1-Phenyl)ethyl hydroperoxide. Rf 0.20
(petroleum ether:MTBE, 4:1); HPLC (Chiralcel OD-H,
hexane:i-PrOH, 95:5, 0.5 mL/min, 20°C): tR=23.2 min
(R) and 28.4 min (S).